Dr. Zhang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
- Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2008 - 2011
- Tongji Medical UniversityClass of 1997
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2023 - 2026
- TN State Medical License 2023 - 2026
- TX State Medical License 2012 - 2026
- WA State Medical License 2023 - 2026
- AL State Medical License 2023 - 2025
- GA State Medical License 2023 - 2025
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study Start of enrollment: 2018 Nov 13
- Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial Start of enrollment: 2021 Jul 20
Roles: Principal Investigator, Contact
- Clinical Study of Ivonescimab for First-line Treatment of Metastatic Squamous NSCLC Patients Start of enrollment: 2023 Oct 26
Roles: Contact
Publications & Presentations
PubMed
- Dietary intake of isoflavones and coumestrol and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.Chunliang Liu, Michael Reger, Hao Fan, Jintao Wang, Jianjun Zhang
British Journal of Cancer. 2025-02-01 - Associations Between Intakes of Carotenoids and Tocopherols with Risk of Pancreatic Cancer in a Population-Based Case-Control Study.Tianchen Sheng, Bronson Dokmanovich, Yunpeng Yu, Chunliang Liu, Hao Fan
Journal of the American Nutrition Association. 2025-02-01 - 2 citationsA Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve-Mutant Metastatic Non-Small Cell Lung...Xiuning Le, Jyoti D Patel, Elaine Shum, Christina Baik, Rachel E Sanborn
Journal of Clinical Oncology. 2025-02-01
Journal Articles
- Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients with EGFR Mutant Metastatic Non-Small Cell Lung Cancer (NSCLC)Xiuning Le, Jianjun Zhang, John V Heymach, Clinical Lung Cancer
- Profiles of Brain Metastases: Prioritization of Therapeutic TargetsRaymond Sawaya, Zoran Gatalica, Isabella C Glitza, John V Heymach, Michael E Salacz, Michael A Davies, Amy B Heimberger, Nuhad K Ibrahim, Jianjun Zhang, Sherise D Ferg..., International Journal of Cancer
- Landscape of EGFR -Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Post-Progression in EGFR-Mutant NSCLCStephen G Swisher, Vassiliki A Papadimitrakopoulou, John V Heymach, Jack A Roth, Jianjun Zhang, William N William, Bonnie S Glisson, Clinical Cancer Research
Authored Content
- Intake of Methyl-Related Nutrients and Risk of Pancreatic Cancer in a Population-Based Case-Control Study in MinnesotaJune 2018
Press Mentions
- MD Anderson Research Highlights for January 9, 2025January 9th, 2025
- Innovative Directions in Immunotherapy ResearchSeptember 11th, 2024
- MD Anderson Research Highlights for December 6, 2021December 6th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: